Literature DB >> 27453275

Mesenchymal stem cell-derived exosomes: A novel potential therapeutic avenue for cardiac regeneration.

S Safari1, F Malekvandfard2, S Babashah3, A Alizadehasl4, M Sadeghizadeh3, M Motavaf5.   

Abstract

Coronary artery diseases (CADs) represent a significant cause of death worldwide. During recent decades the rate of cardiovascular mortality has been declined as a result of modern medicine and surgery. However, despite the fact that cardiac cells, including cardiomyocytes (CMCs), vascular smooth muscle cells (VSMC) and vascular endothelial cells (VEC), can be regenerated by cardiac adult stem cell, the regenerative capacity of these cells are limited and inadequate to functionally regenerate heart damaged tissue. Thus, growth reserve of the heart fails to restore the structural integrity of the myocardium after infarction and healing is associated with scar formation. An explanation for this is that cardiac reside stem cells are present throughout the infarction site but die rapidly by apoptosis. Furthermore, microenvironment surrounding the damage site is not promising for the cells survival and renewal. Hence, recent advances in the stem cell therapy have emerged as an attractive approach to replace the lost cells. In this context, mesenchymal stem cells (MSCs) has considered as one of the most promising candidates for regeneration of cardiac cells, lost upon injury. The regenerative capacity of MSCs has primarily been centered on the hypothesis that these cells would engraft, differentiate and replace damaged cardiac cells. However, experimental and clinical observations so far have failed to establish if this differentiated is considerably relevant to MSCs cardiac regenerative properties. Recent reports have suggested that these therapeutic properties, at least in part, are mediated by paracrine factors released from MSCs. This review provides a concise summary of current evidences supporting the paracrine hypothesis of MSCs. In particular, the scope of this review focuses on the role of MSC-derived exosome (MSC-EXs) as a therapeutic modality for the treatment of CADs, particularly ischemic myocardial dysfunctions.

Entities:  

Mesh:

Year:  2016        PMID: 27453275

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  12 in total

1.  Engineering a naturally-derived adhesive and conductive cardiopatch.

Authors:  Brian W Walker; Roberto Portillo Lara; Chu Hsiang Yu; Ehsan Shirzaei Sani; William Kimball; Shannon Joyce; Nasim Annabi
Journal:  Biomaterials       Date:  2019-03-21       Impact factor: 12.479

2.  Long noncoding RNA expression profiles in chondrogenic and hypertrophic differentiation of mouse mesenchymal stem cells.

Authors:  Zhen Cao; Song Huang; Jianmei Li; Yun Bai; Ce Dou; Chuan Liu; Fei Kang; Xiaoshan Gong; Haibin Ding; Tianyong Hou; Shiwu Dong
Journal:  Funct Integr Genomics       Date:  2017-07-22       Impact factor: 3.410

3.  Extracellular vesicles: small bricks for tissue repair/regeneration.

Authors:  Simona Taverna; Marzia Pucci; Riccardo Alessandro
Journal:  Ann Transl Med       Date:  2017-02

4.  Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair.

Authors:  Ju-Ro Lee; Bong-Woo Park; Jonghoon Kim; Yeon Woong Choo; Han Young Kim; Jeong-Kee Yoon; Hyeok Kim; Ji-Won Hwang; Mikyung Kang; Sung Pil Kwon; Seuk Young Song; In Ok Ko; Ji-Ae Park; Kiwon Ban; Taeghwan Hyeon; Hun-Jun Park; Byung-Soo Kim
Journal:  Sci Adv       Date:  2020-05-01       Impact factor: 14.136

5.  Immunosuppressive Effect of Exosomes from Mesenchymal Stromal Cells in Defined Medium on Experimental Colitis.

Authors:  Zhi Jie Ma; Yun Hong Wang; Zhi Gang Li; Ying Wang; Bing Yao Li; Hui Yan Kang; Xiao Yun Wu
Journal:  Int J Stem Cells       Date:  2019-11-30       Impact factor: 2.500

6.  Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle-Mediated Delivery of miRNA.

Authors:  Golnar Shojaati; Irona Khandaker; Martha L Funderburgh; Mary M Mann; Rohan Basu; Donna B Stolz; Moira L Geary; Aurélie Dos Santos; Sophie X Deng; James L Funderburgh
Journal:  Stem Cells Transl Med       Date:  2019-07-10       Impact factor: 6.940

Review 7.  Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles.

Authors:  Abdelnaby Khalyfa; Anabel L Castro-Grattoni; David Gozal
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 8.  Extracellular Vesicles in Cardiovascular Theranostics.

Authors:  Yihua Bei; Saumya Das; Rodosthenis S Rodosthenous; Paul Holvoet; Maarten Vanhaverbeke; Marta Chagas Monteiro; Valter Vinicius Silva Monteiro; Jana Radosinska; Monika Bartekova; Felix Jansen; Qian Li; Johnson Rajasingh; Junjie Xiao
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556

Review 9.  Lab-on-Chip for Exosomes and Microvesicles Detection and Characterization.

Authors:  Maria Serena Chiriacò; Monica Bianco; Annamaria Nigro; Elisabetta Primiceri; Francesco Ferrara; Alessandro Romano; Angelo Quattrini; Roberto Furlan; Valentina Arima; Giuseppe Maruccio
Journal:  Sensors (Basel)       Date:  2018-09-20       Impact factor: 3.576

Review 10.  How to Stimulate Myocardial Regeneration in Adult Mammalian Heart: Existing Views and New Approaches.

Authors:  Galina Belostotskaya; Marc Hendrikx; Michael Galagudza; Sergey Suchkov
Journal:  Biomed Res Int       Date:  2020-03-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.